Parkman Healthcare Partners LLC - Q3 2021 holdings

$395 Million is the total value of Parkman Healthcare Partners LLC's 74 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 36.6% .

 Value Shares↓ Weighting
DXCM SellDEXCOM INC$24,859,000
+15.4%
45,458
-9.9%
6.29%
+33.5%
ACRS SellACLARIS THERAPEUTICS INC$23,516,000
-10.8%
1,306,460
-13.0%
5.95%
+3.2%
AVTR BuyAVANTOR INC$17,996,000
+43.2%
440,000
+24.3%
4.55%
+65.7%
UTHR  UNITED THERAPEUTICS CORP DEL$17,410,000
+2.9%
94,3240.0%4.40%
+19.1%
IQV BuyIQVIA HLDGS INC$16,736,000
+1.0%
69,869
+2.2%
4.23%
+16.9%
ALNY  ALNYLAM PHARMACEUTICALS INC$14,155,000
+11.4%
74,9670.0%3.58%
+28.9%
DHR SellDANAHER CORPORATION$13,798,000
-7.9%
45,324
-18.8%
3.49%
+6.6%
SGEN BuySEAGEN INC$12,340,000
+73.0%
72,676
+60.9%
3.12%
+100.3%
CRL SellCHARLES RIV LABS INTL INC$10,317,000
-46.6%
25,000
-52.1%
2.61%
-38.2%
NTRA SellNATERA INC$10,035,000
-26.7%
90,047
-25.3%
2.54%
-15.1%
COO BuyCOOPER COS INC$9,956,000
+35.2%
24,088
+29.6%
2.52%
+56.5%
GOSS  GOSSAMER BIO INC$9,891,000
+54.8%
786,8700.0%2.50%
+79.1%
PODD SellINSULET CORP$9,760,000
+0.6%
34,340
-2.8%
2.47%
+16.4%
CDMO SellAVID BIOSERVICES INC$9,707,000
-20.3%
450,000
-5.3%
2.46%
-7.8%
FULC BuyFULCRUM THERAPEUTICS INC$9,557,000
+523.0%
338,796
+131.4%
2.42%
+621.8%
HZNP BuyHORIZON THERAPEUTICS PUB L$8,738,000
+29.1%
79,767
+10.4%
2.21%
+49.5%
RCUS SellARCUS BIOSCIENCES INC$8,252,000
+21.8%
236,637
-4.1%
2.09%
+41.0%
IMUX BuyIMMUNIC INC$8,178,000
+61.1%
924,087
+123.2%
2.07%
+86.4%
ABBV NewABBVIE INC$8,090,00075,000
+100.0%
2.05%
APEN BuyAPOLLO ENDOSURGERY INC$7,531,000
+34.5%
831,214
+20.3%
1.90%
+55.6%
HUM SellHUMANA INC$7,394,000
-48.9%
19,000
-41.9%
1.87%
-40.8%
CDXS BuyCODEXIS INC$6,654,000
+42.5%
286,067
+38.8%
1.68%
+64.8%
RGEN SellREPLIGEN CORP$5,780,000
-25.3%
20,000
-48.4%
1.46%
-13.5%
CTLT SellCATALENT INC$5,288,000
-10.6%
39,739
-27.4%
1.34%
+3.4%
IDXX  IDEXX LABS INC$4,768,000
-1.5%
7,6670.0%1.21%
+14.0%
XENE SellXENON PHARMACEUTICALS INC$4,755,000
-36.3%
311,207
-22.4%
1.20%
-26.3%
XRAY SellDENTSPLY SIRONA INC$4,670,000
-33.2%
80,455
-27.2%
1.18%
-22.6%
IONS  IONIS PHARMACEUTICALS INC$4,574,000
-15.9%
136,3800.0%1.16%
-2.7%
MRVI  MARAVAI LIFESCIENCES HLDGS I$4,417,000
+17.6%
90,0000.0%1.12%
+36.1%
AMGN NewAMGEN INC$4,253,00020,000
+100.0%
1.08%
DRNA SellDICERNA PHARMACEUTICALS INC$4,227,000
-62.8%
209,686
-31.2%
1.07%
-57.0%
BRKS NewBROOKS AUTOMATION INC NEW$4,094,00040,000
+100.0%
1.04%
PFMT BuyPERFORMANT FINL CORP$3,870,000
+107.5%
977,334
+96.5%
0.98%
+140.0%
KOD  KODIAK SCIENCES INC$3,523,000
+3.2%
36,7020.0%0.89%
+19.4%
HBIO BuyHARVARD BIOSCIENCE INC$3,318,000
-1.0%
475,367
+18.1%
0.84%
+14.5%
RCM NewR1 RCM INC$3,191,000145,000
+100.0%
0.81%
AXGN SellAXOGEN INC$3,160,000
-38.5%
200,000
-15.8%
0.80%
-28.9%
SMLR NewSEMLER SCIENTIFIC INC$3,125,00024,998
+100.0%
0.79%
STRO  SUTRO BIOPHARMA INC$3,086,000
+1.6%
163,3890.0%0.78%
+17.6%
ATEC NewALPHATEC HLDGS INC$3,048,000250,000
+100.0%
0.77%
BCYC SellBICYCLE THERAPEUTICS PLCsponsored ads$2,893,000
+17.9%
69,549
-14.0%
0.73%
+36.6%
ETNB Buy89BIO INC$2,857,000
+12.5%
145,848
+7.4%
0.72%
+30.3%
NOTV SellINOTIV INC$2,851,000
-7.1%
97,500
-15.2%
0.72%
+7.5%
ANIP BuyANI PHARMACEUTICALS INC$2,801,000
+44.4%
85,346
+54.2%
0.71%
+67.2%
BBIO  BRIDGEBIO PHARMA INC$2,717,000
-23.1%
57,9780.0%0.69%
-11.1%
SUPN  SUPERNUS PHARMACEUTICALS INC$2,678,000
-13.4%
100,4150.0%0.68%
+0.3%
SIEN BuySIENTRA INC$2,531,000
+5.4%
441,746
+46.4%
0.64%
+21.9%
HCAT  HEALTH CATALYST INC$2,526,000
-9.9%
50,5150.0%0.64%
+4.2%
MDGL SellMADRIGAL PHARMACEUTICALS INC$2,505,000
-29.3%
31,393
-13.7%
0.63%
-18.2%
OM SellOUTSET MED INC$2,489,000
-29.2%
50,336
-28.4%
0.63%
-18.0%
STXS SellSTEREOTAXIS INC$2,421,000
-63.0%
450,000
-33.7%
0.61%
-57.2%
VCYT NewVERACYTE INC$2,090,00045,000
+100.0%
0.53%
TKNO NewALPHA TEKNOVA INC$2,025,00081,372
+100.0%
0.51%
ALT SellALTIMMUNE INC$1,979,000
+0.5%
175,000
-12.5%
0.50%
+16.2%
IRTC NewIRHYTHM TECHNOLOGIES INC$1,903,00032,500
+100.0%
0.48%
SURF BuySURFACE ONCOLOGY INC$1,879,000
+10.3%
248,267
+8.8%
0.48%
+27.7%
SDGR BuySCHRODINGER INC$1,810,000
-21.8%
33,108
+8.2%
0.46%
-9.5%
REPH  RECRO PHARMA INC$1,588,000
-10.8%
770,8330.0%0.40%
+3.3%
BCRX SellBIOCRYST PHARMACEUTICALS INC$1,465,000
-73.7%
101,961
-71.0%
0.37%
-69.5%
TELA  TELA BIO INC$1,366,000
-15.2%
100,0000.0%0.35%
-1.7%
ONCT SellONCTERNAL THERAPEUTICS INC$1,357,000
-31.2%
325,384
-21.7%
0.34%
-20.4%
ICAD SellICAD INC$1,344,000
-85.4%
125,000
-76.5%
0.34%
-83.1%
BLRX SellBIOLINERX LTDsponsored ads$1,130,000
-45.2%
411,060
-44.0%
0.29%
-36.6%
MNKD SellMANNKIND CORP$1,109,000
-74.7%
255,047
-68.3%
0.28%
-70.7%
VCEL  VERICEL CORP$993,000
-7.0%
20,3400.0%0.25%
+7.7%
MTEM  MOLECULAR TEMPLATES INC$951,000
-14.2%
141,6630.0%0.24%
-0.4%
CSLT SellCASTLIGHT HEALTH INCcl b$942,000
-47.1%
600,000
-11.5%
0.24%
-39.0%
ZYME NewZYMEWORKS INC$871,00030,000
+100.0%
0.22%
OPNT NewOPIANT PHARMACEUTICALS INC$772,00030,000
+100.0%
0.20%
KRMD BuyREPRO MED SYS INC$645,000
-30.8%
226,256
+12.4%
0.16%
-20.1%
CBIO SellCATALYST BIOSCIENCES INC$548,000
-67.8%
133,449
-66.1%
0.14%
-62.7%
VSTM BuyVERASTEM INC$541,000
+5.7%
175,797
+39.7%
0.14%
+22.3%
VERA SellVERA THERAPEUTICS INCcl a$445,000
-55.6%
25,638
-66.1%
0.11%
-48.4%
CALA  CALITHERA BIOSCIENCES INC$219,000
+4.3%
100,6280.0%0.06%
+19.6%
EYEG ExitEYEGATE PHARMACEUTICALS INC$0-75,647
-100.0%
-0.06%
AMAM ExitAMBRX BIOPHARMA INCsponsored ads$0-15,000
-100.0%
-0.06%
ARPO ExitAERPIO PHARMACEUTICALS INC$0-353,957
-100.0%
-0.13%
AUPH ExitAURINIA PHARMACEUTICALS INC$0-49,969
-100.0%
-0.14%
ASLN ExitASLAN PHARMACEUTICALS LTDads$0-225,881
-100.0%
-0.16%
BCEL ExitATRECA INC$0-100,628
-100.0%
-0.19%
FBRX ExitFORTE BIOSCIENCES INC$0-31,402
-100.0%
-0.23%
TLMD ExitSOC TELEMED INC$0-208,121
-100.0%
-0.26%
NTLA ExitINTELLIA THERAPEUTICS INC$0-7,500
-100.0%
-0.26%
KDMN ExitKADMON HLDGS INC$0-501,740
-100.0%
-0.42%
ExitTRILLIUM THERAPEUTICS INC$0-211,385
-100.0%
-0.45%
EDAP ExitEDAP TMS S Asponsored adr$0-346,926
-100.0%
-0.54%
SPNE ExitSEASPINE HLDGS CORP$0-225,000
-100.0%
-1.01%
INFU ExitINFUSYSTEM HLDGS INC$0-251,567
-100.0%
-1.14%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-130,000
-100.0%
-1.28%
NVRO ExitNEVRO CORP$0-35,792
-100.0%
-1.30%
XLRN ExitACCELERON PHARMA INC$0-60,074
-100.0%
-1.65%
ITMR ExitITAMAR MED LTDsponsored ads$0-338,001
-100.0%
-1.74%
ISRG ExitINTUITIVE SURGICAL INC$0-19,613
-100.0%
-3.94%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-12
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEXCOM INC16Q3 20236.3%
ACLARIS THERAPEUTICS INC16Q3 202310.0%
XENON PHARMACEUTICALS INC16Q3 20233.3%
NATERA INC16Q3 20233.4%
AVID BIOSERVICES INC15Q3 20232.9%
SCHRODINGER INC15Q3 20234.2%
REPRO MED SYS INC15Q2 20232.0%
MANNKIND CORP15Q3 20231.6%
IQVIA HLDGS INC14Q1 20234.6%
INSULET CORP14Q3 20232.9%

View Parkman Healthcare Partners LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Parkman Healthcare Partners LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PLUS THERAPEUTICS, INC.February 13, 2023583,4671.7%

View Parkman Healthcare Partners LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-12
SC 13G/A2023-02-13
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11

View Parkman Healthcare Partners LLC's complete filings history.

Compare quarters

Export Parkman Healthcare Partners LLC's holdings